Targeted gene modification in mouse ES cells using integrase-defective lentiviral vectors

Yuka Okada, Yuko Ueshin, Hidetoshi Hasuwa, Kazuhiro Takumi, Masaru Okabe, Masahito Ikawa

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Lentiviral vectors efficiently integrate into the host genome of both dividing and nondividing cells, and so they have been used for stable transgene expression in biological and biomedical studies. However, recent studies have highlighted the risk of insertional mutagenesis and subsequent oncogenesis. Here, we used an integrase-defective lentiviral (IDLV) vector to decrease the chance of random integration and examined the feasibility of lentiviral vector-mediated gene targeting into murine embryonic stem (ES) cells. After transduction with wild-type lentiviral vectors, none of the 512 G418 resistant clones were found to be homologous recombinant clones. Although the transduction efficiency was lower with the IDLV vectors (5.9% of wild-type), successful homologous recombination was observed in nine out of the 941 G418 resistant clones (0.83 ± 1.32%). Pluripotency of the homologous recombinant ES cells was confirmed by the production of chimeric mice and subsequent germ line transmission. Because lentiviral vectors can efficiently transduce a variety of stem cell types, our strategy has potential relevance for secure gene-manipulation in therapeutic applications.

Original languageEnglish
Pages (from-to)217-223
Number of pages7
JournalGenesis
Volume47
Issue number4
DOIs
Publication statusPublished - 2009
Externally publishedYes

Fingerprint

Integrases
Clone Cells
Embryonic Stem Cells
Genes
Gene Targeting
Insertional Mutagenesis
Homologous Recombination
Transgenes
Germ Cells
Carcinogenesis
Stem Cells
Genome
Mouse Embryonic Stem Cells
antibiotic G 418
Therapeutics

Keywords

  • Gene targeting
  • Gene therapy
  • Homologous recombination
  • Knockout
  • Lentivirus

ASJC Scopus subject areas

  • Endocrinology
  • Cell Biology
  • Genetics

Cite this

Targeted gene modification in mouse ES cells using integrase-defective lentiviral vectors. / Okada, Yuka; Ueshin, Yuko; Hasuwa, Hidetoshi; Takumi, Kazuhiro; Okabe, Masaru; Ikawa, Masahito.

In: Genesis, Vol. 47, No. 4, 2009, p. 217-223.

Research output: Contribution to journalArticle

Okada, Yuka ; Ueshin, Yuko ; Hasuwa, Hidetoshi ; Takumi, Kazuhiro ; Okabe, Masaru ; Ikawa, Masahito. / Targeted gene modification in mouse ES cells using integrase-defective lentiviral vectors. In: Genesis. 2009 ; Vol. 47, No. 4. pp. 217-223.
@article{eaa15fdde6954494a636227b1dab7248,
title = "Targeted gene modification in mouse ES cells using integrase-defective lentiviral vectors",
abstract = "Lentiviral vectors efficiently integrate into the host genome of both dividing and nondividing cells, and so they have been used for stable transgene expression in biological and biomedical studies. However, recent studies have highlighted the risk of insertional mutagenesis and subsequent oncogenesis. Here, we used an integrase-defective lentiviral (IDLV) vector to decrease the chance of random integration and examined the feasibility of lentiviral vector-mediated gene targeting into murine embryonic stem (ES) cells. After transduction with wild-type lentiviral vectors, none of the 512 G418 resistant clones were found to be homologous recombinant clones. Although the transduction efficiency was lower with the IDLV vectors (5.9{\%} of wild-type), successful homologous recombination was observed in nine out of the 941 G418 resistant clones (0.83 ± 1.32{\%}). Pluripotency of the homologous recombinant ES cells was confirmed by the production of chimeric mice and subsequent germ line transmission. Because lentiviral vectors can efficiently transduce a variety of stem cell types, our strategy has potential relevance for secure gene-manipulation in therapeutic applications.",
keywords = "Gene targeting, Gene therapy, Homologous recombination, Knockout, Lentivirus",
author = "Yuka Okada and Yuko Ueshin and Hidetoshi Hasuwa and Kazuhiro Takumi and Masaru Okabe and Masahito Ikawa",
year = "2009",
doi = "10.1002/dvg.20469",
language = "English",
volume = "47",
pages = "217--223",
journal = "Genesis",
issn = "1526-954X",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Targeted gene modification in mouse ES cells using integrase-defective lentiviral vectors

AU - Okada, Yuka

AU - Ueshin, Yuko

AU - Hasuwa, Hidetoshi

AU - Takumi, Kazuhiro

AU - Okabe, Masaru

AU - Ikawa, Masahito

PY - 2009

Y1 - 2009

N2 - Lentiviral vectors efficiently integrate into the host genome of both dividing and nondividing cells, and so they have been used for stable transgene expression in biological and biomedical studies. However, recent studies have highlighted the risk of insertional mutagenesis and subsequent oncogenesis. Here, we used an integrase-defective lentiviral (IDLV) vector to decrease the chance of random integration and examined the feasibility of lentiviral vector-mediated gene targeting into murine embryonic stem (ES) cells. After transduction with wild-type lentiviral vectors, none of the 512 G418 resistant clones were found to be homologous recombinant clones. Although the transduction efficiency was lower with the IDLV vectors (5.9% of wild-type), successful homologous recombination was observed in nine out of the 941 G418 resistant clones (0.83 ± 1.32%). Pluripotency of the homologous recombinant ES cells was confirmed by the production of chimeric mice and subsequent germ line transmission. Because lentiviral vectors can efficiently transduce a variety of stem cell types, our strategy has potential relevance for secure gene-manipulation in therapeutic applications.

AB - Lentiviral vectors efficiently integrate into the host genome of both dividing and nondividing cells, and so they have been used for stable transgene expression in biological and biomedical studies. However, recent studies have highlighted the risk of insertional mutagenesis and subsequent oncogenesis. Here, we used an integrase-defective lentiviral (IDLV) vector to decrease the chance of random integration and examined the feasibility of lentiviral vector-mediated gene targeting into murine embryonic stem (ES) cells. After transduction with wild-type lentiviral vectors, none of the 512 G418 resistant clones were found to be homologous recombinant clones. Although the transduction efficiency was lower with the IDLV vectors (5.9% of wild-type), successful homologous recombination was observed in nine out of the 941 G418 resistant clones (0.83 ± 1.32%). Pluripotency of the homologous recombinant ES cells was confirmed by the production of chimeric mice and subsequent germ line transmission. Because lentiviral vectors can efficiently transduce a variety of stem cell types, our strategy has potential relevance for secure gene-manipulation in therapeutic applications.

KW - Gene targeting

KW - Gene therapy

KW - Homologous recombination

KW - Knockout

KW - Lentivirus

UR - http://www.scopus.com/inward/record.url?scp=66149094732&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66149094732&partnerID=8YFLogxK

U2 - 10.1002/dvg.20469

DO - 10.1002/dvg.20469

M3 - Article

C2 - 19208434

AN - SCOPUS:66149094732

VL - 47

SP - 217

EP - 223

JO - Genesis

JF - Genesis

SN - 1526-954X

IS - 4

ER -